Video

Pfizer CentreOne Capacity Update October 2024: Large Molecule Drug Substance

Source: Pfizer CentreOne Large Molecule Biologics

With over 35 years of expertise, our specialized manufacturing site in Sanford, NC, is dedicated to elevating the quality and success of your monoclonal antibody (mAb) therapies. Equipped with advanced capabilities in both adherent and suspension cell culture processes, Sanford delivers industry-leading yield and productivity, backed by the strength of Pfizer’s global network to accelerate the journey of innovative therapies to patients.

Discover how Pfizer CentreOne can support your mAb drug substance and product needs, bringing your vision to life with unmatched expertise.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.

Subscribe to Drug Discovery Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Drug Discovery Online

Please tell us more about you so that we can customize our newsletters to your specific interests: